Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Emulated-target Trial for Guiding Stratified Treatment for Renal Cell Carcinoma With Venous Tumor Thrombus

NCT07117227 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT07117227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07117227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Emulated-target Trial for Guiding Stratified Treatment for Renal Cell Carcinoma With Venous Tumor Thrombus
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2025
Completion date
August 1, 2027
Enrollment
4,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

observational study, prognosis, prognostic cancer model, real world study, renal cell carcinoma (kidney cancer), renal cell carcinoma (rcc), tumor thrombus